Economic impact of self-administered subcutaneous versus clinic-administered intravenous immunoglobulin G therapy in Alberta, Canada: a population-based cohort study.

"Declarations Ethics approval and consent to participateEthics approval (Pro00086993) was obtained from the institutional review board at the University of Alberta. This is a study of administrative data without any intervention. No study participants were placed at risk as a result of this study, and informed consent was not required. Consent for publicationNot applicable. Competing interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: SK and KM are members of the Real-World Evidence Unit, an academic entity at the University of Alberta that conducts research including investigator-initiated industry-funded studies. HB received advisory board honoraria from Shire Canada and CSL Behring Canada, and an honorarium for consultation from CSL Behring Canada. No other conflict of interest is declared. All authors of this study had complete autonomy over the content and submission of the manuscript, as well as the design and execution of the study. Competing interests The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: SK and KM are members of the Real-World Evidence Unit, an academic entity at the University of Alberta that conducts research including investigator-initiated industry-funded studies. HB received advisory board honoraria from Shire Canada and CSL Behring Canada, and an honorarium for consultation from CSL Behring Canada. No other conflict of interest is declared. All authors of this study had complete autonomy over the content and submission of the manuscript, as well as the design and execution of the study."

"Funding This research study was funded by CSL Behring. The funders had no role in the study design, analysis, interpretation of the data, drafting of the manuscript, or in the decision to submit for publication. The funders had the right to comment on the manuscript prior to submission, but the final decision regarding content and submission of the manuscript remained with the corresponding author."